Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.

A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
A M Szczepanik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L R Brougham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J E Roehr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P G Conway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D B Ellis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C A Wilmot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 278 no. 2 913-920
PubMed 
8768747

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online August 1, 1996.


Author Information

  1. A M Szczepanik,
  2. L R Brougham,
  3. J E Roehr,
  4. P G Conway,
  5. D B Ellis and
  6. C A Wilmot
  1. Neuroscience Therapeutic Area, Hoechst Marion Roussel, Inc., Somerville, New Jersey, USA.

    Statistics from Altmetric.com

    Article usage

    Article usage: February 1999 to July 2022

    AbstractFullPdf
    Feb 1999200
    Aug 2000200
    Sep 2000100
    Oct 2000100
    Dec 2000200
    Mar 2001300
    May 2001300
    Dec 2001100
    Mar 2002100
    Jul 2002200
    Aug 2002100
    Feb 2003100
    Jul 2003100
    Aug 2003300
    Sep 2003500
    Oct 2003900
    Nov 2003600
    Dec 2003400
    Jan 2004800
    Feb 2004700
    Mar 2004400
    Apr 2004600
    May 2004400
    Jun 2004700
    Jul 2004800
    Aug 20041300
    Sep 2004900
    Oct 2004900
    Nov 20041300
    Dec 20041000
    Jan 20051000
    Feb 2005800
    Mar 20051200
    Apr 2005300
    May 2005200
    Jun 2005500
    Jul 2005500
    Aug 2005200
    Sep 2005200
    Oct 2005400
    Nov 2005600
    Dec 2005700
    Jan 2006400
    Feb 2006900
    Mar 2006500
    Apr 2006301
    May 2006101
    Jun 2006400
    Jul 2006100
    Aug 2006200
    Sep 2006503
    Oct 2006101
    Nov 20061402
    Dec 20061004
    Jan 2007602
    Feb 2007800
    Mar 2007501
    Apr 2007100
    May 2007805
    Jun 2007601
    Aug 2007200
    Sep 2007303
    Oct 2007205
    Nov 2007304
    Dec 2007701
    Jan 2008101
    Feb 2008600
    Mar 2008306
    Apr 2008401
    May 20081405
    Jun 2008601
    Jul 2008703
    Aug 2008300
    Sep 2008300
    Oct 20081103
    Nov 2008500
    Dec 2008300
    Jan 2009300
    Feb 2009400
    Mar 2009303
    Apr 2009300
    May 20091603
    Jun 20091004
    Jul 2009801
    Aug 2009504
    Sep 2009902
    Oct 20099017
    Nov 20091203
    Dec 200910019
    Jan 2010808
    Feb 20101505
    Mar 20101204
    Apr 2010501
    May 2010704
    Jun 20102706
    Jul 2010805
    Aug 2010301
    Sep 2010703
    Oct 2010600
    Nov 2010903
    Dec 2010808
    Jan 2011704
    Feb 2011801
    Mar 20111406
    Apr 2011602
    May 2011903
    Jun 2011903
    Jul 2011700
    Aug 2011401
    Sep 2011600
    Oct 2011502
    Nov 20111109
    Dec 2011801
    Jan 2012503
    Feb 2012402
    Mar 2012400
    Apr 2012701
    May 2012701
    Jun 2012100
    Jul 2012901
    Aug 2012300
    Sep 2012300
    Oct 20121700
    Nov 2012504
    Dec 2012201
    Jan 2013400
    Feb 2013300
    Mar 2013300
    Apr 201312013
    May 2013401
    Jun 2013302
    Jul 2013200
    Sep 2013300
    Oct 2013301
    Nov 2013100
    Dec 2013200
    Jan 2014200
    Feb 2014200
    Apr 2014100
    May 2014001
    Jul 2014100
    Aug 2014100
    Oct 2014100
    Nov 2014100
    Dec 2014200
    Jan 2015100
    Mar 2015300
    May 2015300
    Jun 2015002
    Jul 2015101
    Sep 2015102
    Dec 2015400
    Jan 2016101
    Mar 2016401
    Apr 2016300
    May 2016802
    Jun 2016400
    Aug 2016302
    Sep 2016101
    Oct 2016300
    Nov 2016500
    Dec 2016200
    Jan 2017300
    Feb 2017501
    Mar 2017300
    Apr 2017100
    May 2017500
    Jun 20171400
    Jul 2017900
    Aug 2017400
    Sep 2017500
    Oct 2017600
    Nov 20171701
    Dec 2017500
    Jan 2018300
    Feb 2018600
    Mar 2018801
    Apr 2018600
    May 2018600
    Jun 2018600
    Jul 2018500
    Aug 2018500
    Sep 2018300
    Oct 2018400
    Nov 2018300
    Dec 2018400
    Feb 2019600
    Mar 2019100
    Apr 2019501
    May 2019100
    Jun 2019106
    Sep 2019200
    Oct 2019200
    Nov 2019800
    Dec 2019400
    Jan 2020100
    Feb 2020300
    Mar 2020200
    Jul 2020201
    Aug 2020100
    Sep 2020600
    Oct 2020600
    Nov 2020401
    Dec 2020300
    Jan 2021500
    Feb 20211000
    Mar 2021600
    Apr 2021400
    May 2021400
    Jun 2021300
    Jul 2021600
    Aug 20211000
    Sep 2021300
    Oct 2021400
    Nov 20211300
    Dec 2021400
    Jan 2022800
    Feb 2022300
    Mar 2022300
    Apr 2022800
    May 2022600
    Jun 20221100
    Jul 2022100

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics
    Vol. 278, Issue 2
    1 Aug 1996
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.

    A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
    Journal of Pharmacology and Experimental Therapeutics August 1, 1996, 278 (2) 913-920;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.

    A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
    Journal of Pharmacology and Experimental Therapeutics August 1, 1996, 278 (2) 913-920;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics